Endo USA, Inc. recalls
5 recall notices naming Endo USA, Inc. since January 2025, in United States. The most recent was published 20 May 2026.
Latest recalls (5)
- ENDO USA, Inc. recalls Buprenorphine HydrochlorideFDACrystallization; identified as Buprenorphine free base
- Endo USA, Inc. recalls Everolimus tablets 7.5mg and 3 moreFDAFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- Endo USA, Inc. recalls Everolimus tablets 5mgFDAFailed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
- ENDO USA, Inc. recalls Adrenalin Chloride Solution (Epinephrine Nasal SolutionFDALabeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)
- Endo USA, Inc. recalls Clonazepam Orally Disintegrating Tablets and 1 moreFDALabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct…